The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds for example, indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
本发明涉及
尼古丁乙酰胆碱受体(nAChR)
配体、nAChR的激活以及与缺陷或功能失调的
尼古丁乙酰胆碱受体相关的疾病状态的治疗,特别是与大脑相关的疾病状态。此外,本发明涉及新型化合物,例如
吲哚、1H-
吲哚唑、1,2-苯并
异噁唑和1,2-苯并异
硫噻唑,它们作为α7 nAChR亚型的
配体,制备这种化合物的方法,含有这种化合物的组合物以及使用这种化合物的方法。